Clinical efficacy and safety of vorinostat in relapsed/refractory CTCL
Publication
, Conference
Olsen, EA; Duvic, M
Published in: ANNALS OF ONCOLOGY
June 1, 2008
Duke Scholars
Published In
ANNALS OF ONCOLOGY
ISSN
0923-7534
Publication Date
June 1, 2008
Volume
19
Start / End Page
156 / 156
Location
Lugano, SWITZERLAND
Publisher
OXFORD UNIV PRESS
Conference Name
10th International Conference on Malignant Lymphoma
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Olsen, E. A., & Duvic, M. (2008). Clinical efficacy and safety of vorinostat in relapsed/refractory CTCL. In ANNALS OF ONCOLOGY (Vol. 19, pp. 156–156). Lugano, SWITZERLAND: OXFORD UNIV PRESS.
Olsen, E. A., and M. Duvic. “Clinical efficacy and safety of vorinostat in relapsed/refractory CTCL.” In ANNALS OF ONCOLOGY, 19:156–156. OXFORD UNIV PRESS, 2008.
Olsen EA, Duvic M. Clinical efficacy and safety of vorinostat in relapsed/refractory CTCL. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2008. p. 156–156.
Olsen, E. A., and M. Duvic. “Clinical efficacy and safety of vorinostat in relapsed/refractory CTCL.” ANNALS OF ONCOLOGY, vol. 19, OXFORD UNIV PRESS, 2008, pp. 156–156.
Olsen EA, Duvic M. Clinical efficacy and safety of vorinostat in relapsed/refractory CTCL. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2008. p. 156–156.
Published In
ANNALS OF ONCOLOGY
ISSN
0923-7534
Publication Date
June 1, 2008
Volume
19
Start / End Page
156 / 156
Location
Lugano, SWITZERLAND
Publisher
OXFORD UNIV PRESS
Conference Name
10th International Conference on Malignant Lymphoma
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis